Healthcare - Biotechnology - NASDAQ - US
$ 1.14
2.7 %
$ 3.37 M
Market Cap
-0.1
P/E
Price Target
Average
2356.14%
Revenue Forecast
Estimate
6.24%
EBIT
Estimate
60.65%
Net Income
Estimate
22.80%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Oncternal Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for ONCT of $28 , with forecasts ranging from a low of $28 to a high of $28 .
ONCT Lowest Price Target
Wall Street Target
28 USD
2356.14%
ONCT Average Price Target
Wall Street Target
28 USD
2356.14%
ONCT Highest Price Target
Wall Street Target
28 USD
2356.14%
REVENUE FORECAST
Revenue Forecast Chart ONCT
EBIT FORECAST
EBIT Forecast Chart ONCT
NET INCOME FORECAST
Net Income Chart ONCT